Wendy Dixon

She formerly served as chief marketing officer and president of global marketing at Bristol-Myers Squibb Co. In her 30-year career in the biopharmaceutical industry she also held senior positions at Merck, Osteotech, Centocor, and SmithKline & French, now part of GlaxoSmithKline. Also is a director of Orexigen Therapeutics, Dentsply, and Furiex Pharmaceuticals.

  • 2010 Second Quarter

Added to: Incyte Corp. - Wilmington, DE

Incyte is a drug discovery and development company. Revenues are $3 billion.